TrialDrug design, development and therapy2018

A randomized, double-blind clinical trial of canrenone vs hydrochlorothiazide in addition to angiotensin II receptor blockers in hypertensive type 2 diabetic patients.

Giuseppe Derosa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.